Tumor News and Research

RSS

Single Cell Tracking Explains Why Certain Cancer Cells Survive Treatments

A comprehensive multi-cancer study from researchers at The University of Texas MD Anderson Cancer Center has revealed that cancer cells within tumors are genetically diverse, yet all carry the same core genetic changes that can be traced back to a common ancestral cell, providing a single-cell view of how tumors adapt, survive and diversify.

17 Jun 2026

Scientists Discover Genetic Root of Rare Childhood Inflammatory Skin Disorder

An international team of researchers has identified a genetic cause for a rare inflammatory skin condition.

15 Jun 2026

Peking University Researchers Map High Dimensional Cellular Networks in Tumors

A comprehensive review led by Associate Researcher Linnan Zhu and Academician Zemin Zhang at Biomedical Pioneering Innovation Center (BIOPIC), Peking University, China, and Chongqing Medical University, China, was published in Volume 2, article number 27 of the journal Immunity & Inflammation on June 05, 2026.

13 Jun 2026

New Protein Storage Condensates May Hold Clues for Better Anticancer Strategies

A team of Johns Hopkins Bloomberg School of Public Health researchers has discovered large droplets of proteins known as condensates near inactive chromosome regions within the cell nucleus that are a feature of some cancer cells and may hold clues for better anticancer strategies.

12 Jun 2026

Body Clock Protein Drives Macrophages Into Pro-Inflammatory States

Daily life is shaped by the solar day, influencing when we wake up, eat, work, and sleep. Inside the body, a similar internal timing system -present in nearly every cell- known as the circadian clock, synchronizes many biological functions such as sleep, metabolism, hormone release, and even the immune system's activity.

12 Jun 2026

Building More Realistic Human Tissue Models With Assembloids

Assembloids combine organoids and specialized cells, creating advanced models for drug testing and regenerative medicine with improved physiological relevance.

11 Jun 2026

Laverock Therapeutics Reports Key Oncology Research Milestones

Laverock Therapeutics, a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its T-cell and macrophage oncology program for solid tumor indications.

From Laverock Therapeutics 11 Jun 2026

New Cell Therapy Modifies Natural Killer Cells Against Cancer

Scientists have made great progress in harnessing the body's own immune cells to treat so-called liquid tumors, cancers of the blood and lymphatic system.

11 Jun 2026

Researchers Outline Dynamic Protein Control Systems for Better Clinical Decisions

Cancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but these layers do not fully explain why tumors with similar genetic profiles can behave differently.

10 Jun 2026

Scientists Identify EHMT2 Enzyme as Main Cause of 5-FU Failure

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients.

9 Jun 2026

Scottish Biotech Bead Biopharma Emerges From Stealth Mode with Novel Cancer Drug Platform

Bead BioPharma, a Scottish life sciences company backed by Archangels, today announced its emergence from stealth mode following the submission of its first patent, a milestone that marks the company’s formal entry into one of the most commercially active sectors in global oncology.

9 Jun 2026

Creatine Linked to Cancer-Fighting Dendritic Cell Function

According to recent UCLA research, creatine, the organic acid that athletes and bodybuilders frequently use as a supplement, supercharges a crucial class of immune cells that activate and prime the body's primary cancer-fighting agents.

8 Jun 2026

New Study Proves Research Models Accurately Replicate Cancer ecDNA Loops

Damage to DNA in cancer cells can lead to pieces breaking off chromosomes and floating away, like icebergs cracking off from a glacier. Just as icebergs are a threat to ships and their crew, these scattered bits of DNA loom large to physicians and cancer patients by having titanic effects on tumor progression and treatment resistance.

8 Jun 2026

Blood Signature Found to Predict Lung Cancer Risk Years Before Diagnosis

Researchers have identified a blood signature that can predict lung cancer risk years before diagnosis – significant findings that could enhance prevention strategies for Australia’s biggest cancer killer.

5 Jun 2026

New Chromosome Packaging Discovery Explains Unlimited Growth in Cancer Cells

Published today in Nature, researchers at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center report a previously unrecognized change in how the cell's genetic material is packaged into structures called chromosomes.

4 Jun 2026

Webinar - Modality Agnostic Drug Discovery Strategies for Data Sparse Targets: Lessons Learned From Avammune & Cresset, Hosted by Visioneers

Are you working on data-sparse or novel targets? Join us June 11th to learn how Avammune progressed from early concepts to trial-stage candidates in this space.

From Cresset 4 Jun 2026